|
Patient eligibility criteria |
| Inclusion criteria: |
| • Patient agreed with and signed the "informed consent" form |
| • Adult patients (≥ 18 years old) [Mature Skeleton] |
| • Patients with isolated, acute (no more than 2 weeks between injury and treatment), non-displaced complete fracture of the mid third of the scaphoid, without any dislocation or comminution visible on the CT scan (long axial 1-mm cuts, high resolution) |
| Exclusion criteria: |
| • Patients with acute fractures of both hands |
| • Patients with one hand missing |
| • All injuries other than isolated scaphoid fractures |
| • Patients with radiological signs of carpal instability |
| • Patients with signs of any rheumatoid, osteoarthritis or polyarthritis |
| • Patients with previous skeletal or severe soft tissue trauma to the same wrist |
| • History of drug or alcohol abuse |
| • General or local conditions adversely affecting bone physiology |
| • Patients unlikely to cooperate or attend all scheduled visits |
| • Patients who have participated in any other device or drug clinical trial within the previous month |
| • Patients with physical or mental incapacity, which makes it impossible to obtain informed consent |
| • Patients with legal incompetence |
Pfeiffer et al. BMC Musculoskeletal Disorders 2006 7:41 doi:10.1186/1471-2474-7-41 |